Clinical
What’s to come at AAHA: January 2026
Ring in the new year with fresh learning opportunities from AAHA!
Clinical
383 Articles
Clinical
Vetmedin chewable tablets receive full FDA approval for delay of congestive heart failure in dogs label indication
After three years of expanded conditional approval, Vetmedin chewable tablets are now fully FDA approved for the delay of onset of congestive heart failure in dogs.
Clinical
First ever Emergency Use Authorization granted for veterinary drug Credelio (and what that means for veterinary medicine)
The FDA recenly granted Elanco an Emergency Use Authorization (EUA) for their product, Credelio. Learn more here!
Clinical
Credelio Quattro-CA1 receives conditional approval from the FDA to treat New World Screwworm
Credelio Quattro-CA1 now has a new indication on its label in the fight to protect dogs from the threat of New World Screwworm.
Clinical
VIDEO: 2026 AAHA Oncology Guidelines Preview with Sue Ettinger, DVM, DACVIM (Oncology)
In this video, Dr. Ettinger offers a preview of AAHA’s upcoming Oncology Guidelines, launching January 2, 2026.
Clinical
A compassionate approach to feline cognitive dysfunction
When it comes to feline cognitive dysfunction, vigilant screening, clear communication, and a flexible management plan allow veterinarians to enrich the human-animal bond through supportive care.
Clinical
JAAHA: How does time of antimicrobial administration impact the outcome for septic dogs?
A new study in JAAHA aims to determine if the time to antimicrobial administration, as well as time to appropriate antimicrobial administration, impacted hospitalization time of dogs diagnosed with sepsis.
Clinical
From the guidelines: Feline hyperaldosteronism
Considered a rare disease, feline primary hyperaldosteronism (PHA) is most commonly caused by a unilateral adrenocortical adenoma, a benign tumor on one of the adrenal glands.
Clinical
Study reveals shared biology with plants may be key to new toxoplasmosis treatments
Researchers are exploiting Toxoplasma gondii‘s shared biology with plants to discover new treatment options for chronic toxoplasmosis in humans and animals.
Clinical
FDA greenlights new injectable maropitant for dogs and cats
Maropitant citrate is widely used in veterinary medicine as an antiemetic for dogs and cats. Now, there will be two FDA-approved injectable forms on the market.
